Inhibitor Therapeutics, Inc. (INTI)

0.0641 -0.01 (-14.56%) USD  |  OTCM  |  Jan 20, 09:52
More

Inhibitor Therapeutics EV to CFO

EV to CFO Chart

View EV to CFO for INTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EV to CFO Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EV to CFO Range, Past 5 Years

View EV to CFO Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EV to CFO Benchmarks

View EV to CFO Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade
NanoViricides, Inc. Upgrade

EV to CFO Related Metrics

EV to Free Cash Flow Upgrade
EV to Assets (Quarterly) Upgrade
EV to Earnings Upgrade